Genprex Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement, Still Faces Minimum Bid Price Challenge

Reuters

06-09

Genprex Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement, Still Faces Minimum Bid Price Challenge

Genprex Inc. announced that it has successfully regained compliance with Nasdaq's minimum stockholders' equity requirement, as confirmed in a letter from Nasdaq's Listing Qualifications Department on June 6, 2025. Previously, the company had been notified in November 2024 that it was not meeting the minimum stockholders' equity of $2.5 million. However, based on Genprex's recent quarterly report, Nasdaq has confirmed that the company now meets the necessary requirements, resolving the prior issue. Additionally, Genprex is working to address another compliance matter regarding the minimum bid price of its common stock, which remains below the required $1.00 per share. The company has until August 6, 2025, to rectify this situation and is considering strategies such as a reverse stock split to meet Nasdaq's standards.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-019767), on June 09, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2542216386"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2542216386\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2542216386?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-09 19:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2542216386","market":"nz","top_or_hot":-1,"title":"Genprex Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement, Still Faces Minimum Bid Price Challenge","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Genprex Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement, Still Faces Minimum Bid Price Challenge\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Genprex Inc. announced that it has successfully regained compliance with Nasdaq's minimum stockholders' equity requirement, as confirmed in a letter from Nasdaq's Listing Qualifications Department on June 6, 2025. Previously, the company had been notified in November 2024 that it was not meeting the minimum stockholders' equity of $2.5 million. However, based on Genprex's recent quarterly report, Nasdaq has confirmed that the company now meets the necessary requirements, resolving the prior issue. Additionally, Genprex is working to address another compliance matter regarding the minimum bid price of its common stock, which remains below the required $1.00 per share. The company has until August 6, 2025, to rectify this situation and is considering strategies such as a reverse stock split to meet Nasdaq's standards.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-019767), on June 09, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Genprex Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement, Still Faces Minimum Bid Price Challenge</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenprex Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement, Still Faces Minimum Bid Price Challenge\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-06-09 19:01</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Genprex Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement, Still Faces Minimum Bid Price Challenge\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Genprex Inc. announced that it has successfully regained compliance with Nasdaq's minimum stockholders' equity requirement, as confirmed in a letter from Nasdaq's Listing Qualifications Department on June 6, 2025. Previously, the company had been notified in November 2024 that it was not meeting the minimum stockholders' equity of $2.5 million. However, based on Genprex's recent quarterly report, Nasdaq has confirmed that the company now meets the necessary requirements, resolving the prior issue. Additionally, Genprex is working to address another compliance matter regarding the minimum bid price of its common stock, which remains below the required $1.00 per share. The company has until August 6, 2025, to rectify this situation and is considering strategies such as a reverse stock split to meet Nasdaq's standards.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-019767), on June 09, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GNPX","symbol_name":"Genprex, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nNDL5Yc8PQ:1","article_id":"2542216386","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2542216386","pubTimestamp":1749466873,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Genprex Inc. announced that it has successfully regained compliance with Nasdaq's minimum stockholders' equity requirement, as confirmed in a letter from Nasdaq's Listing Qualifications Department on June 6, 2025. Previously, the company had been notified in November 2024 that it was not meeting the minimum stockholders' equity of $2.5 million. However, based on Genprex's recent quarterly report, Nasdaq has confirmed that the company now meets the necessary requirements, resolving the prior issue. Additionally, Genprex is working to address another compliance matter regarding the minimum bid price of its common stock, which remains below the required $1.00 per share. The company has until August 6, 2025, to rectify this situation and is considering strategies such as a reverse stock split to meet Nasdaq's standards.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"GNPX":"Genprex, Inc.","BK4139":"生物科技"},"translate_title":"Genprex Inc.重新遵守纳斯达克股东股权要求，但仍面临最低买入价挑战","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GNPX":0.9},"content_text":"Genprex Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement, Still Faces Minimum Bid Price Challenge\n    \n\n        Genprex Inc. announced that it has successfully regained compliance with Nasdaq's minimum stockholders' equity requirement, as confirmed in a letter from Nasdaq's Listing Qualifications Department on June 6, 2025. Previously, the company had been notified in November 2024 that it was not meeting the minimum stockholders' equity of $2.5 million. However, based on Genprex's recent quarterly report, Nasdaq has confirmed that the company now meets the necessary requirements, resolving the prior issue. Additionally, Genprex is working to address another compliance matter regarding the minimum bid price of its common stock, which remains below the required $1.00 per share. The company has until August 6, 2025, to rectify this situation and is considering strategies such as a reverse stock split to meet Nasdaq's standards.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-019767), on June 09, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}